Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Oral and Oromucosal Melatonin (Melaform)
NCT02107079Phase 1Completed
- Sponsor
- Utrecht University
- Start
- Jan 2012
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of melatonin in Insomnia, sponsored by Utrecht University. Primary endpoint: Melatonin concentration in saliva at 3 hours. Started Jan 2012; status: completed.
02
Drugs
melatonin
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT02107079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02107079.